0000899140-24-000250.txt : 20240214 0000899140-24-000250.hdr.sgml : 20240214 20240214163104 ACCESSION NUMBER: 0000899140-24-000250 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 EFFECTIVENESS DATE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 ORGANIZATION NAME: IRS NUMBER: 900924432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15935 FILM NUMBER: 24639114 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001577524 XXXXXXXX 12-31-2023 12-31-2023 false Sarissa Capital Management LP
660 STEAMBOAT ROAD GREENWICH CT 06830
13F HOLDINGS REPORT 028-15935 N
Alexander J. Denner, Ph.D. Chief Investment Officer 203-302-2330 /s/ Alexander J. Denner Greenwich CT 01-30-2024 0 9 648896720
INFORMATION TABLE 2 informationtable.xml AMARIN CORP PLC SPONS ADR NEW 023111206 21620042 24850623 SH SOLE 24850623 0 0 BIOCRYST PHARMACEUTICALS INC COM 09058V103 5990000 1000000 SH SOLE 1000000 0 0 BIOGEN INC COM 09062X103 166389110 643000 SH SOLE 643000 0 0 GILEAD SCIENCES INC COM 375558103 87118154 1075400 SH SOLE 1075400 0 0 INNOVIVA INC COM 45781M101 116723080 7277000 SH SOLE 7277000 0 0 IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 187501600 16390000 SH SOLE 16390000 0 0 NEUROCRINE BIOSCIENCES INC COM 64125C109 61927200 470000 SH SOLE 470000 0 0 REGULUS THERAPEUTICS INC COM 75915K309 237034 185183 SH SOLE 185183 0 0 VOR BIOPHARMA INC COM 929033108 1390500 618000 SH SOLE 618000 0 0